Niraparib,abiraterone,Prednisone
Janssen
['brca', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
second interim analysis of magnitude: maintained rpfs benefit in the brca subgroup for abi-nira #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid